Shares of Glenmark Pharmaceuticals today rallied over 3 per cent on HSBC rating.
The stock jumped as much as 3.4 per cent as HSBC has upgraded the stock to “buy’’ from “hold’’.
The company has reported below forecast earnings for December quarter.
All negatives are priced in and the stock is trading 20 per cent cheaper to peers, HSBC says.